Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (381-390 of 1,137) with videos related to

Pageof 114
Sort By:
The American Journal of Cardiology|October 24, 2007
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines databaseBenjamin A Steinberg, Christopher P Cannon, Adrian F Hernandez, et al.
Orbit (Amsterdam, Netherlands)|October 30, 2019
Combined neurosurgical and orbital intervention for spheno-orbital meningiomas - the Manchester experienceJ Young, F Mdanat, A Dharmasena, et al.
JAMA Cardiology|August 3, 2017
Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular DiseaseChristopher P Cannon, Irfan Khan, Alexa C Klimchak, et al.
European Heart Journal|October 12, 2017
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists CollaborationBrian A Ference, Christopher P Cannon, Ulf Landmesser, et al.
Journal of the American College of Cardiology|July 16, 2016
Reply: Personalize and Optimize Lipid-Lowering TherapiesSabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
The American Journal of Cardiology|November 13, 2001
Seasonal variation of myocardial infarct sizeR A Kloner, S Das, W K Poole, et al.
European Heart Journal|February 25, 2011
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndromeBabak Nazer, Kausik K Ray, Sarah Sloan, et al.
Critical Pathways in Cardiology|July 26, 2017
Quality Improvement in Management of Acute Coronary Syndrome: Continuing Medical Education and Peer Coaching Improve Antiplatelet Medication Adherence and Reduce Hospital ReadmissionsAmy Larkin, Michael LaCouture, Kathleen Geissel, et al.
Journal of the American College of Cardiology|June 25, 2016
Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?Sabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
Immunogenetics|March 12, 2008
Evidence for a transposition event in a second NITR gene cluster in zebrafishJeffrey A Yoder, John P Cannon, Ronda T Litman, et al.
Pageof 114

Showing results (381-390 of 1,137) with videos related to

Sort By:
Pageof 114
The American Journal of Cardiology|October 24, 2007
Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines databaseBenjamin A Steinberg, Christopher P Cannon, Adrian F Hernandez, et al.
Orbit (Amsterdam, Netherlands)|October 30, 2019
Combined neurosurgical and orbital intervention for spheno-orbital meningiomas - the Manchester experienceJ Young, F Mdanat, A Dharmasena, et al.
JAMA Cardiology|August 3, 2017
Simulation of Lipid-Lowering Therapy Intensification in a Population With Atherosclerotic Cardiovascular DiseaseChristopher P Cannon, Irfan Khan, Alexa C Klimchak, et al.
European Heart Journal|October 12, 2017
Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists CollaborationBrian A Ference, Christopher P Cannon, Ulf Landmesser, et al.
Journal of the American College of Cardiology|July 16, 2016
Reply: Personalize and Optimize Lipid-Lowering TherapiesSabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
The American Journal of Cardiology|November 13, 2001
Seasonal variation of myocardial infarct sizeR A Kloner, S Das, W K Poole, et al.
European Heart Journal|February 25, 2011
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndromeBabak Nazer, Kausik K Ray, Sarah Sloan, et al.
Critical Pathways in Cardiology|July 26, 2017
Quality Improvement in Management of Acute Coronary Syndrome: Continuing Medical Education and Peer Coaching Improve Antiplatelet Medication Adherence and Reduce Hospital ReadmissionsAmy Larkin, Michael LaCouture, Kathleen Geissel, et al.
Journal of the American College of Cardiology|June 25, 2016
Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?Sabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
Immunogenetics|March 12, 2008
Evidence for a transposition event in a second NITR gene cluster in zebrafishJeffrey A Yoder, John P Cannon, Ronda T Litman, et al.
Pageof 114